Average Co-Inventor Count = 2.89
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Harvard College (17 from 2,961 patents)
2. The General Hospital Corporation (17 from 2,886 patents)
3. Acetylon Pharmaceuticals, Inc. (16 from 35 patents)
4. Dana-farber-cancer Institute Inc. (14 from 1,207 patents)
5. Regenacy Pharmaceuticals, LLC (12 from 16 patents)
6. Children's Medical Center Corporation (6 from 1,036 patents)
7. Other (1 from 832,718 patents)
8. Massachusetts Institute of Technology (1 from 8,370 patents)
9. Genzyme Corporation (1 from 787 patents)
10. Whitehead Institute for Biomedical Research (1 from 303 patents)
11. Howard Hughes Medical Institute (1 from 118 patents)
12. Erx Pharmaceuticals Corporation (1 from 1 patent)
13. The General Hospital Corporation D/b/a Massachusetts General Hospital (1 patent)
62 patents:
1. 12134721 - Complexes and ligands
2. 12064408 - Compounds for the treatment of obesity and methods of use thereof
3. 11858919 - HDAC1,2 inhibitors
4. 11753436 - Analogs of celastrol
5. 11708353 - Inhibitors of prolyl-tRNA-synthetase
6. 11702389 - Piperidine derivatives as HDAC1/2 inhibitors
7. 11617750 - Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
8. 11596691 - Photoswitchable HDAC inhibitors
9. 11542242 - Substituted piperazines as selective HDAC1,2 inhibitors
10. RE49240 - Inhibitors of histone deacetylase
11. 11045439 - Compounds for the treatment of obesity and methods of use thereof
12. 10968180 - Piperidine derivatives as HDAC1/2 inhibitors
13. 10927072 - Phenyl and pyridinyl hydroxamic acids
14. 10828367 - Photoswitchable HDAC inhibitors
15. 10774056 - Substituted piperazines as selective HDAC1,2 inhibitors